Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5599)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • XMT-1660: A phase 1B trial of a B7-H4 targeting antibody drug conjugate (ADC) in endometrial, ovarian, and breast cancers
    Meeting Abstract

    Hamilton, E.; Chaudhry, A.; Spira, A.; Adams, S.; Abuhadra, N.; Giordano, A.; Parajuli, R.; Han, H.; Weise, A.; Marchesani, A.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center
    Meeting Abstract

    Ehmann, S.; Shay, K.; Zhou, Q.; Iasonos, A.; Sonoda, Y.; Gardner, G.; Roche, K. L.; Zammarrelli, W.; O'Cearbhaill, R.; Zivanovic, O.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Sectioning and extensively examining the fimbriated end of fallopian tubes for endometrial cancer
    Meeting Abstract

    Gordhandas, S.; Hodgson, A.; Kahn, R.; Sia, T.; Murali, R.; Leitao, M.; Abu-Rustum, N.; Weigelt, B.; Ellenson, L.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Characterization of long-term/short-term treatment duration in light
    Meeting Abstract

    Liu, Y.; Mathews, C.; Simpkins, F.; Cadoo, K.; Provencher, D.; McCormick, C.; Einaggar, A.; Altman, A.; Gilbert, L.; Black, D.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Real-world experience and common adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
    Meeting Abstract

    Zammarrelli, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Rubinstein, M.; Green, A.; Makker, V.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Genomic instability as a determinant of immune escape in ovarian cancer
    Meeting Abstract

    Vazquez-Garcia, I.; Uhlitz, F.; Ceglia, N.; Lim, J.; Wu, M.; Mohibullah, N.; Niyazov, J.; Ruiz, A. E.; Soslow, R.; Ellenson, L.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • The Impact of hospital surgical volume on survival in early-stage cervical cancer treated with radical hysterectomy: A sub-analysis of the SCCAN study
    Meeting Abstract

    Bizzarri, N.; Dostálek, L.; Lonkhuijzen, Lrcw; Giannarelli, D.; Lopez, A.; Falconer, H.; Querleu, D.; Ayhan, A.; Kim, S. H.; Ortiz, D. I.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: Interim Results of ENGOT Cx8/GOG-3024/innovaTV205
    Meeting Abstract

    Lorusso, D.; Vergote, I.; O'Cearbhaill, R. E.; Westermann, A. M.; Banerjee, S.; van Nieuwenhuysen, E.; Iglesias, D. A.; Collins, D.; Cibula, D.; Madsen, K.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Exploiting SMARCA2 dependency for targeted therapy in SMARCA4-deficient ovarian cancers
    Meeting Abstract

    Brodeur, M.; Dopeso, H.; Green, H.; Ito, K.; Hulse, M.; Brown, J.; Weigelt, B.; Zamarin, D.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Clinical benefit of mirvetuximab soravtansine in ovarian cancer patients with high folate receptor alpha expression: Results from the SORAYA Study
    Meeting Abstract

    Coleman, R. L.; Matulonis, U.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. R.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save